For­get Hong Kong, Grail is now go­ing for a 2019 IPO in the US — Bloomberg

In tes­ta­ment to the murky sen­ti­ment hang­ing over the Hong Kong stock ex­change — and hot on a record-break­ing streak of pub­lic de­buts state­side — high-fly­ing can­cer test­ing start­up Grail has re­port­ed­ly dropped its plans for a Hong Kong list­ing in fa­vor of the US mar­ket.

Months af­ter get­ting the scoop on Grail’s in­ten­tion to list on the HKEX, Bloomberg is now re­port­ing that Grail is mulling a US IPO in­stead, with a fil­ing ex­pect­ed as ear­ly as 2019, cit­ing un­named sources.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.